PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, NYU Grossman School of Medicine, New York, New York, USA.\', \'Thrivewell Infusion, LLC, Brooklyn, New York, USA.\', \'Department of Anesthesiology, Mount Sinai Hospital-Brooklyn, Brooklyn, New York, USA.\', \'Department of Internal Medicine, Englewood Hospital, Englewood, New Jersey, USA.\', \'Department of Internal Medicine, CarePoint Health System-Christ Hospital, Jersey City, New Jersey, USA.\', \'Departments of Internal Medicine and Environmental Medicine, NYU School of Medicine, New York, New York, USA.\', \'Department of Anesthesiology, NYC Health + Hospitals/Bellevue, New York, New York, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1089/scd.2020.0080
?:doi
?:hasPublicationType
?:journal
  • Stem cells and development
is ?:pmid of
?:pmid
?:pmid
  • 32380908
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.426
?:rankingScore_hIndex
  • 94
is ?:relation_isRelatedTo_publication of
?:title
  • Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all